DF Dent & Co’s Teva Pharmaceuticals TEVA Stock Holding History

DF Dent & Co’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,197	Closed	-$307K	–	193
2015 Q2	$307K	Buy	+5,197	New	+$321K	0.01%	165

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DF Dent & Co's TEVA Position: Q3 2015 in Review

DF Dent & Co sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 5,197 shares — an estimated $307K sold.

DF Dent & Co first reported a position in TEVA in Q2 2015 and held it in 1 quarter. The position peaked at $307K in Q2 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

DF Dent & Co reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
DF Dent & Co sold 5,197 Teva Pharmaceuticals shares in Q3 2015, an estimated $307K.
DF Dent & Co first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 1 quarter.
DF Dent & Co's Teva Pharmaceuticals position peaked at $307K in Q2 2015.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on DF Dent & Co's 13F filing for Q3 2015, filed 19 Nov 2015.